This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Big Stories For the Rest of 2014

Obamacare Lives

The Affordable Care Act (ACA) - otherwise known as Obamacare - may go the way of Medicaid and Medicare. By that, I mean to say the law may simply become an entrenched part of the U.S. healthcare system that has its critics but isn't a major topic of discussion.

Businesses, the media and many Americans may have rumbled about Obamacare and even made it a priority of recent election cycles; however, those concerns may be receding. The majority of private U.S. companies are in compliance with Obamacare even though some requirements have been delayed until 2015, global consultancy PwC reported in July Trendsetter report. Meanwhile, Obamacare's impact on company decision making may be minimal.

Must Read: David Einhorn Causes athenaHealth Rout: Highlights from Ira Sohn 2014

Just 3% of companies expect to drop healthcare coverage as a result of Obamacare, PwC said in July. Ken Esch, who led the Trendsetter report, said in a telephone interview Wednesday that companies may have found their employee plans required little change as Obamacare was implemented. Meanwhile, a recovering labor market may have meant employers decided against changes to their healthcare plans, fearing a loss of talent to competitors.

Signups for Obamacare surpassed 8 million, the government reported earlier in May. Meanwhile, threats to the policy like a bad age mix of signups or payment defaults, don't appear to have been borne out.

By year-end, Obamacare may simply become a part of the way America does business.

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VZ $44.92 -0.60%
BRK.B $135.13 -0.30%
CMCSA $61.40 -0.42%
KO $43.36 0.00%
TMUS $36.97 -3.70%


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs